CellGate acquired by Australian cancer biotech ProGen for $2.5M

February 4, 2008 | David P. Hamilton | Comments | |

See our story about this Redwood City, Calif., biotech in today’s daily briefing at VentureBeat Life Sciences.

Next Story: Yahoo ends Music Unlimited, what about its DRM-free service in the works?
Previous Story: PEAK Surgical’s plasma-based electrosurgical tools net it $21M

Bookmark and Share

Photo of David P. Hamilton

About the Author, David P. Hamilton

David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.